KIT D816 Mutation Analysis (Mastocytosis)
Test Code
Clinical Significance
KIT D816 Mutation Analysis (Mastocytosis) - Point mutation of the KIT oncogene at codon 816 (D816V) is seen in >90% of systemic mastocytosis (SM) cases. The presence of KIT D816V mutation is one of the minor criteria for diagnosis of SM and mutation testing can assist in diagnosis, particularly in limited specimens. KIT D816 mutations, including D816V, D816H and D816Y, are also the most common KIT mutations seen in the core-binding factor acute myeloid leukemia (AML). In both t(8;21) and inv(16)/t(16;16) AML, cases with KIT D816 mutation are associated with worse outcomes than unmutated cases.
This PCR-based DNA pyrosequencing ...
Test Resources
Test Summary
KIT D816 Mutation Analysis (Mastocytosis)Test Details
Methodology
Reference Range(s)
Preferred Specimen(s)
5 mL whole blood collected in an EDTA (lavender-top) tube
Alternative Specimen(s)
Whole blood collected in: Sodium heparin (green-top) or ACD-B (yellow-top) tube • 2 mL bone marrow aspirate collected in an EDTA (lavender-top) tube • Formalin-fixed, paraffin-embedded tissue block • 10 slides tissue submitted in a slide holder
Minimum Volume
2 mL whole blood • 0.5 mL bone marrow • 6 slides
Transport Container
EDTA (lavender-top) tube
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
- Refrigerated: 7 days
- Frozen: Unacceptable
Reject Criteria
Received frozen
Setup Schedule
Refrigerated: 7 days
Frozen: Unacceptable